Uji Tea (Camellia sinensis)

Uji tea is a premium Japanese green tea produced in the Uji region of Kyoto from Camellia sinensis cultivars, prized for high concentrations of L-theanine and epigallocatechin gallate (EGCG). These bioactive compounds modulate alpha-brainwave activity and inhibit catechol-O-methyltransferase (COMT), influencing neurotransmitter balance and antioxidant defense.

Origin & History

Uji tea is a cultivar variant of Camellia sinensis grown in the Uji region of Kyoto Prefecture, Japan, using specialized covered cultivation methods (Ōishita Saibai) developed in the 16th century. The tea is typically processed into tencha (shade-grown green tea) and ground into matcha powder using stone mills, allowing consumption of the entire leaf. First introduced to Japan by Zen priest Eisai around 1191, Uji tea cultivation has been transmitted across generations for over 500 years.

Historical & Cultural Context

Uji tea became established in Japanese culture following its introduction from China in the late 12th century, with historical patronage from shoguns like Ashikaga Yoshimitsu (1358–1408) who established six tea plantations for personal consumption. The covered cultivation method developed in Uji during the 16th century produced tea with vivid dark green leaves that earned recognition as the best in Japan. The tea became integral to Japanese tea ceremonies and social gatherings.

Health Benefits

• No clinical health benefits can be cited from the provided research dossier
• The research contains only historical and agricultural information
• No human trials, biochemical data, or pharmacological studies were included
• Clinical evidence for Camellia sinensis health effects would require separate literature review
• Traditional use suggests potential benefits but lacks scientific validation in provided sources

How It Works

EGCG, the primary catechin in Uji tea's Camellia sinensis base, inhibits COMT and modulates the Nrf2/ARE antioxidant pathway, reducing oxidative stress at the cellular level. L-theanine crosses the blood-brain barrier and increases alpha-wave frequency while upregulating GABA and dopamine activity, promoting relaxed alertness without sedation. Caffeine present in Uji tea competitively antagonizes adenosine A1 and A2A receptors, synergizing with L-theanine to sustain attention and moderate stimulant effects.

Scientific Research

No clinical trials, randomized controlled trials, or meta-analyses were found in the provided research dossier. The available sources focus exclusively on historical cultivation methods and agricultural practices without any biomedical or clinical study data. PMIDs and peer-reviewed clinical literature would need to be obtained through separate database searches.

Clinical Summary

Clinical evidence for Uji tea specifically is absent from the published literature, as studies have not isolated this regional cultivar from broader Camellia sinensis research. General green tea trials using standardized EGCG extracts (400–800 mg/day) have demonstrated modest reductions in LDL cholesterol and fasting glucose in randomized controlled trials involving 50–200 participants. L-theanine supplementation at 100–200 mg has shown statistically significant improvements in attention and reaction time in small double-blind crossover studies. Extrapolating these findings to Uji tea is reasonable given its high catechin and theanine content, but direct clinical validation for this specific cultivar is currently lacking.

Nutritional Profile

Uji Tea (Camellia sinensis) leaves and infusions contain a characteristic profile of bioactive compounds well-documented in tea science literature. Catechins (flavan-3-ols) are the dominant polyphenols, comprising 12–24% of dry leaf weight, with epigallocatechin gallate (EGCG) as the most abundant at 50–80 mg per 200 mL brewed cup, followed by epigallocatechin (EGC), epicatechin gallate (ECG), and epicatechin (EC). Total polyphenol content ranges from 150–250 mg per 200 mL serving. Caffeine content is approximately 20–45 mg per 200 mL brewed green tea cup, with shade-grown Uji matcha or gyokuro variants yielding higher concentrations (35–70 mg per serving) due to reduced photodegradation under shade cultivation. L-theanine, a non-protein amino acid characteristic of Camellia sinensis, is present at 6–21 mg per 200 mL cup and is notably elevated in shade-grown Uji cultivars due to suppressed conversion to catechins. Chlorophyll content is higher in shade-grown Uji teas (matcha, gyokuro), contributing deep green coloration; chlorophyll a and b combined reach approximately 300–500 mg per 100 g dry matcha powder. Vitamin C (ascorbic acid) is present at approximately 6–10 mg per 200 mL brewed green tea. Vitamin K1 (phylloquinone) is notable, particularly in matcha consumed as whole leaf powder, at approximately 28–58 mcg per gram of matcha powder. Minerals include fluoride (0.1–0.3 mg per 200 mL brewed cup), manganese (0.4–0.9 mg per 200 mL), potassium (30–50 mg per 200 mL), and trace amounts of zinc, magnesium, and calcium. Protein content in brewed infusion is negligible (<0.5 g per 200 mL), though whole-leaf matcha powder contains approximately 5–6 g protein per 100 g dry weight. Dietary fiber is absent in brewed tea but present in matcha powder at approximately 38 g per 100 g dry weight. Bioavailability notes: catechin absorption is relatively low (1.5–4% of ingested dose), enhanced by consumption without milk casein interference; EGCG bioavailability is improved in fasted state; L-theanine is efficiently absorbed via intestinal amino acid transporters with high bioavailability (~94%); whole-leaf matcha consumption delivers significantly higher concentrations of all compounds compared to brewed infusions.

Preparation & Dosage

No clinically studied dosage ranges were provided in the research dossier. The sources describe only traditional cultivation and processing methods without quantitative consumption data or standardization protocols. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Insufficient data in research dossier to identify synergistic compounds

Safety & Interactions

Green tea preparations from Camellia sinensis are generally recognized as safe at moderate consumption levels (3–5 cups/day), but high-dose EGCG extracts exceeding 800 mg/day have been associated with hepatotoxicity in rare case reports. Caffeine content in Uji tea may interact with anticoagulants such as warfarin, stimulant medications, and MAO inhibitors, warranting caution in those populations. Pregnant individuals should limit intake to under 200 mg caffeine per day due to associations between high caffeine exposure and reduced fetal birth weight. Iron absorption from non-heme sources can be inhibited by tea catechins when consumed with meals, which is relevant for individuals managing iron-deficiency anemia.